Marin: First Two Subjects Treated; Fourth Enrolled

On July 2 and July 6, 2015, the first two subjects were treated in our ongoing study of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness. The fourth subject was enrolled on June 18. Led by Principal Investigator Phil Wolfson, M.D., with co-therapist Julane Andries, LMFT, in Marin, Calif., this study will treat 18 subjects suffering from anxiety related to a life-threatening disease that is either ongoing or in remission with a possibility of recurrence. “We’re not just sitting in an office for 50 minutes,” Dr. Wolfson told the San Francisco Chronicle in a May 24 cover article. “We go for as long as we need in a warm, friendly atmosphere.”